{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O95760",
      "entity_text" : "IL-33",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P35225",
      "entity_text" : "IL-13",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "ILC2 express IL17RB (IL25R) and ST2 (IL33R) and respond to intranasal administration of IL-25 and IL-33 producing IL-13 and IL-5, which contribute to the development of airway hyper-reactivity, eosinophilia, and airway inflammation.",
  "reading_complete" : "2020-08-04T09:35:03Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:31:05Z",
  "trigger" : "producing",
  "evidence" : [ "IL-33 producing IL-13" ],
  "pmc_id" : "6637857",
  "score" : 0
}